Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the toxicity profile, maximum tolerated dose (MTD),
and pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection.